Series A - Etalon Diagnostics

Series A - Etalon Diagnostics

Investment Firm

Overview

Etalon Diagnostics is a biotechnology company specializing in the improvement of the lives of horses.

Announced Date

Nov 23, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Thomas Tull

Thomas Tull

Thomas Tull is a seed firm.

Teton Ridge

Teton Ridge

No designation

Participant Investors

6

Investor Name
Participant InvestorVani Khosla
Participant InvestorRussell Investments
Participant InvestorSigne Ostby
Participant InvestorJohn Quelch
Participant InvestorThomas Tull

Round Details and Background

Etalon Diagnostics raised $18000000 on 2022-11-23 in Series A

Etalon Diagnostics is a biotechnology company specializing in the improvement of the lives of horses.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 10, 2023
Venture Round - Etalon Diagnostics
-209.5K
Nov 23, 2022
Series A - Etalon Diagnostics
12-18.0M

Recent Activity

There is no recent news or activity for this profile.